![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
DG Rhodes, R Newton, R Butler and L Herbette
Biomolecular Structure Analysis Center, University of Connecticut Health Center, Farmington 06030-2017.
The interaction of salmeterol with model membranes has been studied with regard to equilibrium and kinetic behavior, including determination of the membrane-based partition coefficient, the rate of dissociation of salmeterol from membranes, and the rate of association. These data were obtained in various membrane preparations and under various conditions (e.g., temperature, cholesterol content). The compound is very lipophilic, compared with other beta 2 agonists such as salbutamol, and has a rapid association rate and a moderate dissociation rate. The equilibrium data support the assertion that the salmeterol action measured in perfused tissue involves an exo-site for nonspecific binding that may be identified with or related to the lipid bilayer. The kinetic data in unilamellar and multilamellar liposomes of synthetic lipids further suggest that the approach to the exo-site and the active site may involve components in the native system other than the lipid bilayer in which the beta 2 receptor is located. These additional components may explain the slow onset and the extraordinarily long duration of action.
This article has been cited by other articles:
|
|
 |
|
  R. H. Moore, E. E. Millman, V. Godines, N. A. Hanania, T. M. Tran, H. Peng, B. F. Dickey, B. J. Knoll, and R. B. Clark Salmeterol Stimulation Dissociates beta2-Adrenergic Receptor Phosphorylation and Internalization Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 254 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Johnson and S. Rennard Alternative Mechanisms for Long-Acting {beta}2-Adrenergic Agonists in COPD Chest, July 1, 2001; 120(1): 258 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Teschemacher and H. Lemoine Kinetic Analysis of Drug-Receptor Interactions of Long-Acting beta 2 Sympathomimetics in Isolated Receptor Membranes: Evidence against Prolonged Effects of Salmeterol and Formoterol on Receptor-Coupled Adenylyl Cyclase J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1084 - 1092. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. O. Capobianco, D. Zakula, D. J. Frost, R. C. Goldman, L. Li, L. L. Klein, and P. A. Lartey Cellular Accumulation, Localization, and Activity of a Synthetic Cyclopeptamine in Fungi Antimicrob. Agents Chemother., February 1, 1998; 42(2): 389 - 393. [Abstract] [Full Text]
|
|
|
|
|
|
C. I. Ezeamuzie and M. Al-Hage Differential Effects of Salbutamol and Salmeterol on Human Eosinophil Responses J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 25 - 31. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. A. Green, A. P. Spasoff, R. A. Coleman, M. Johnson, and S. B. Liggett Sustained Activation of a G Protein-coupled Receptor via ``Anchored'' Agonist Binding. MOLECULAR LOCALIZATION OF THE SALMETEROL EXOSITE WITHIN THE beta 2-ADRENERGIC RECEPTOR J. Biol. Chem., September 27, 1996; 271(39): 24029 - 24035. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
